STAT

STAT+: Health care leaders plot how to expand diversity in clinical trials

Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
Silas Buchanan, CEO of OurHealthyCommunity, speaks on a panel about democratizing clinical trials at the Milken Institute 2024 Global Conference on May 8, 2024 as Michelle McMurry-Heath, CEO of Biotechquity Clinical looks on.

Even with the that clinical trials often lack the diversity that would make them representative, women and people of color remain underrepresented in

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.
STAT1 min read
STAT+: Pharmalittle: We’re Watching BIO Layoffs, AstraZeneca Plans To Double Revenue, And More
The Biotechnology Innovation Organization on Monday announced 30 layoffs that are part of a restructuring.

Related Books & Audiobooks